Blocking the activity of CD26 with inhibitors (vildagliptin, alogliptin, and linagliptin) antagonized ferroptosis induced by erastin in TP53-/- and TP53-depleted human colorectal cancer cells14. The gene discussed is TP53; the disease is colorectal cancer.